Clinical Trials Directory

Trials / Completed

CompletedNCT06902402

Evaluation of Safety and Efficacy of Three Flavors of Supportan® Drink in Cancer Patients in Taiwan

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
Fresenius Kabi Taiwan Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to demonstrate safety and efficacy of Supportan® Drink (three flavors:Tropical Fruits, Cappuccino, and Pineapple-Coconut), administered as oral nutritional supplement, that will be taken in addition to the patient's normal dietary intake to meet the daily nutritional targets. in cancer patients. The main questions it aims to answer are: Primary Efficacy Endpoint 1. Change in body weight from Baseline to end of treatment at Week 4 (Week 4 -Baseline) Secondary Efficacy Endpoints 1\. Change in CRP from Baseline to Week 2 and to end of treatment at Week 4 (Week 2 - Baseline, Week 4 -Baseline) Participants will be enrolled in one of three flavor group by his/her recruiting time. Each subject needs visit hospital at baseline, week 2 and week 4 for checkups and test. And he/she needs take two bottles of Supportan Drink per day. During the study periods, subjects need write down his/her dietary records every day for evaluation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSupportan® Drink, flavour Tropical Fruitsflavour Tropical Fruits
DIETARY_SUPPLEMENTSupportan® Drink, flavour Cappuccinoflavour Cappuccino
DIETARY_SUPPLEMENTSupportan® Drink, flavour Pineapple-Coconutflavour Pineapple-Coconut

Timeline

Start date
2025-04-08
Primary completion
2025-12-12
Completion
2025-12-12
First posted
2025-03-30
Last updated
2026-04-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06902402. Inclusion in this directory is not an endorsement.